AIDS - Re-emergence of HIV after stopping therapy

被引：363

作者：

Chun, TW ^{[1
]}

Davey, RT ^{[1
]}

Engel, D ^{[1
]}

Lane, HC ^{[1
]}

Fauci, AS ^{[1
]}

机构：

[1] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA

来源：

NATURE | 1999年 / 401卷 / 6756期

关键词：

D O I：

10.1038/44755

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

[No abstract available]

引用

页码：874 / 875

页数：2

共 10 条

[1] Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].

Chun, TW ;

Carruth, L ;

Finzi, D ;

Shen, XF ;

DiGiuseppe, JA ;

Taylor, H ;

Hermankova, M ;

Chadwick, K ;

Margolick, J ;

Quinn, TC ;

Kuo, YH ;

Brookmeyer, R ;

Zeiger, MA ;

BarditchCrovo, P ;

Siliciano, RF .

NATURE, 1997, 387 (6629) :183-188

[2] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].

Chun, TW ;

Stuyver, L ;

Mizell, SB ;

Ehler, LA ;

Mican, JAM ;

Baseler, M ;

Lloyd, AL ;

Nowak, MA ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197

[3] Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection [J].

Chun, TW ;

Engel, D ;

Berrey, MM ;

Shea, T ;

Corey, L ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8869-8873

[4]

CHUN TW, 1999, NAT MED, V5, P615

[5] HIV/AIDS in 1998 - Gaining the upper hand? [J].

Cohen, OJ ;

Fauci, AS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :87-88

[6]

DAVEY RT, IN PRESS P NATL ACAD

[7] Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].

Finzi, D ;

Blankson, J ;

Siliciano, JD ;

Margolick, JB ;

Chadwick, K ;

Pierson, T ;

Smith, K ;

Lisziewicz, J ;

Lori, F ;

Flexner, C ;

Quinn, TC ;

Chaisson, RE ;

Rosenberg, E ;

Walker, B ;

Gange, S ;

Gallant, J ;

Siliciano, RF .

NATURE MEDICINE, 1999, 5 (05) :512-517

[8] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J].

Gulick, RM ;

Mellors, JW ;

Havlir, D ;

Eron, JJ ;

Gonzalez, C ;

McMahon, D ;

Richman, DD ;

Valentine, FT ;

Jonas, L ;

Meibohm, A ;

Emini, EA ;

Chodakewitz, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :734-739

[9] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].

Hammer, SM ;

Squires, KE ;

Hughes, MD ;

Grimes, JM ;

Demeter, LM ;

Currier, JS ;

Eron, JJ ;

Feinberg, JE ;

Balfour, HH ;

Dayton, LR ;

Chodakewitz, JA ;

Fischl, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733

[10] Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy [J].

Zhang, LQ ;

Ramratnam, B ;

Tenner-Racz, K ;

He, YX ;

Vesanen, M ;

Lewin, S ;

Talal, A ;

Racz, P ;

Perelson, AS ;

Korber, BT ;

Markowitz, M ;

Ho, DD .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1605-1613

← 1 →